SCHEMBL12893727

SCHEMBL12893727

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccc(N(c6ccccc6)c6ccc(-n7c8ccccc8c8ccccc87)cc6)cc5)cc4)c4ccccc34)cc21

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HDAC4 P56524 1/20 0.34
▸ PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12893702 0.99 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL262602 0.97 TSPO (0.34) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL12893731 0.96 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL8406181 0.94 KDM4E (0.33) KDM4EATML3MBTL1HDAC4
SCHEMBL12893870 0.94 PDK2 (0.33) PDK2
SCHEMBL14521308 0.94 KDM4E (0.36) KDM4EATML3MBTL1
SCHEMBL12893871 0.94 PDK2 (0.33) PDK2
SCHEMBL262644 0.94 PDK2 (0.33) PDK2
SCHEMBL12893763 0.94 KDM4E (0.35) KDM4EATML3MBTL1HDAC4
SCHEMBL12893728 0.93 PDK2 (0.31) KDM4EATML3MBTL1HDAC4PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879464-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-02-01 — — US disclosed
US-7879464-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-02-01 — — US disclosed
US-20090102360-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-04-23 — — US disclosed
WO-2007013537-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-02-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090102360-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE CRY1, ARNT, AP2A1 KDM4E 1747/4885ATM 392/4885L3MBTL1 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback